Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Pacing Rate for Cardiac Resynchronization Therapy After Atrioventricular Node Ablation in Persistent Atrial Fibrillation and Heart Failure

NCT06445439 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT06445439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06445439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Pacing Rate for Cardiac Resynchronization Therapy After Atrioventricular Node Ablation in Persistent Atrial Fibrillation and Heart Failure
Lead sponsor
Medstar Health Research Institute
Phase
Not applicable
Overall status
Recruiting
Start date
December 19, 2023
Completion date
August 31, 2025
Enrollment
60 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, persistent